These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156 [TBL] [Abstract][Full Text] [Related]
3. Decellularized tissue-engineered heart valves calcification: what do animal and clinical studies tell us? Badria AF; Koutsoukos PG; Mavrilas D J Mater Sci Mater Med; 2020 Dec; 31(12):132. PubMed ID: 33278023 [TBL] [Abstract][Full Text] [Related]
4. [Tissue engineering of heart valves]. Akhyari P; Minol P; Assmann A; Barth M; Kamiya H; Lichtenberg A Chirurg; 2011 Apr; 82(4):311-8. PubMed ID: 21424291 [TBL] [Abstract][Full Text] [Related]
5. Bioreactors for development of tissue engineered heart valves. Berry JL; Steen JA; Koudy Williams J; Jordan JE; Atala A; Yoo JJ Ann Biomed Eng; 2010 Nov; 38(11):3272-9. PubMed ID: 20820920 [TBL] [Abstract][Full Text] [Related]
6. Cells for tissue engineering of cardiac valves. Jana S; Tranquillo RT; Lerman A J Tissue Eng Regen Med; 2016 Oct; 10(10):804-824. PubMed ID: 25712485 [TBL] [Abstract][Full Text] [Related]
7. Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations. Gandaglia A; Bagno A; Naso F; Spina M; Gerosa G Eur J Cardiothorac Surg; 2011 Apr; 39(4):523-31. PubMed ID: 21163670 [TBL] [Abstract][Full Text] [Related]
8. Is Transcatheter Aortic Valve Implantation of Living Tissue-Engineered Valves Feasible? An In Vitro Evaluation Utilizing a Decellularized and Reseeded Biohybrid Valve. Koenig F; Lee JS; Akra B; Hollweck T; Wintermantel E; Hagl C; Thierfelder N Artif Organs; 2016 Aug; 40(8):727-37. PubMed ID: 27187768 [TBL] [Abstract][Full Text] [Related]
9. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681 [TBL] [Abstract][Full Text] [Related]
10. Tissue-engineered heart valve: future of cardiac surgery. Rippel RA; Ghanbari H; Seifalian AM World J Surg; 2012 Jul; 36(7):1581-91. PubMed ID: 22395345 [TBL] [Abstract][Full Text] [Related]
11. Strategies for development of decellularized heart valve scaffolds for tissue engineering. Snyder Y; Jana S Biomaterials; 2022 Sep; 288():121675. PubMed ID: 35953330 [TBL] [Abstract][Full Text] [Related]
17. A review of: application of synthetic scaffold in tissue engineering heart valves. Fallahiarezoudar E; Ahmadipourroudposht M; Idris A; Mohd Yusof N Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():556-65. PubMed ID: 25579957 [TBL] [Abstract][Full Text] [Related]
18. State of the Art: Tissue Engineering in Congenital Heart Surgery. Boyd R; Parisi F; Kalfa D Semin Thorac Cardiovasc Surg; 2019; 31(4):807-817. PubMed ID: 31176798 [TBL] [Abstract][Full Text] [Related]